Cargando…
Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression
BACKGROUND: In an 8-week, randomized, placebo-controlled, double-blind study, an extended-release formulation of quetiapine, quetiapine XR, demonstrated efficacy and safety in Japanese patients with bipolar depression. Bipolar disorder is a chronic disease requiring continuous treatment. METHODS: Th...
Autores principales: | Kanba, Shigenobu, Murasaki, Mitsukuni, Koyama, Tsukasa, Takeuchi, Masahiro, Shimizu, Yuriko, Arita, Eri, Kuroishi, Kentaro, Kamei, Shinya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595609/ https://www.ncbi.nlm.nih.gov/pubmed/31242884 http://dx.doi.org/10.1186/s12888-019-2181-9 |
Ejemplares similares
-
Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression
por: Murasaki, Mitsukuni, et al.
Publicado: (2018) -
Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood Disorders
por: López-Muñoz, Francisco, et al.
Publicado: (2013) -
Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008) -
Childhood trauma and treatment outcomes during mood‐stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder
por: Wrobel, Anna L., et al.
Publicado: (2022) -
Psychosomatic symptoms related to exacerbation of fatigue in patients with medically unexplained symptoms
por: Hashimoto, Kazuaki, et al.
Publicado: (2022)